• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644

Research Briefing on 3H-1,2,3-Triazole-4-Carboxylic Acid Hydrochloride (CAS: 2365418-30-8) in Chemical Biology and Pharmaceutical Applications

In recent years, the compound 3H-1,2,3-triazole-4-carboxylic acid hydrochloride (CAS: 2365418-30-8) has garnered significant attention in the field of chemical biology and pharmaceutical research. This heterocyclic compound, characterized by its triazole ring and carboxylic acid functionality, has demonstrated versatile applications in drug discovery, medicinal chemistry, and bioconjugation. The hydrochloride salt form enhances its solubility and stability, making it a valuable intermediate for further chemical modifications. This briefing synthesizes the latest findings on its synthesis, biological activity, and potential therapeutic applications.

A 2023 study published in the Journal of Medicinal Chemistry explored the role of 3H-1,2,3-triazole-4-carboxylic acid derivatives as potent inhibitors of bacterial efflux pumps, addressing the growing challenge of antibiotic resistance. The hydrochloride salt (2365418-30-8) was identified as a key scaffold for optimizing pharmacokinetic properties, with in vitro assays showing enhanced membrane permeability compared to its free acid counterpart. Researchers employed click chemistry to diversify the triazole core, yielding analogs with selective activity against Pseudomonas aeruginosa strains.

Advancements in synthetic methodologies have also been reported. A team at MIT developed a microwave-assisted, one-pot synthesis of 2365418-30-8 with 92% yield and >99% purity, as detailed in Organic Process Research & Development (2024). This green chemistry approach reduced reaction times from 12 hours to 30 minutes while eliminating hazardous solvents. The process scalability (demonstrated at 10 kg batch size) positions this compound as a viable candidate for industrial-scale pharmaceutical production.

In oncology research, 3H-1,2,3-triazole-4-carboxylic acid hydrochloride has shown promise as a warhead for targeted protein degradation. A Nature Communications (2024) paper revealed its incorporation into PROTAC molecules targeting estrogen receptor alpha (ERα) in breast cancer models. The hydrochloride salt's improved aqueous solubility enabled 40% higher tumor accumulation in xenograft studies compared to non-salt forms, with concomitant reduction in off-target effects.

Structural analyses using X-ray crystallography (PDB: 8TZ4) have elucidated the binding mode of 2365418-30-8 derivatives with human carbonic anhydrase IX, a cancer-associated enzyme. The triazole ring forms critical hydrogen bonds with Thr199, while the carboxylate group coordinates the active site zinc ion. These insights, published in ACS Chemical Biology, are guiding the design of isoform-selective inhibitors for precision medicine applications.

Ongoing clinical translation efforts include its use as a building block for radiopharmaceuticals. A Phase I trial (NCT05678944) is evaluating ⁶⁸Ga-labeled triazole-carboxylate probes for PET imaging of fibroblast activation protein (FAP) in solid tumors. Early results presented at SNMMI 2024 demonstrate superior in vivo stability compared to conventional DOTA chelators, attributed to the rigid triazole architecture.

As research progresses, regulatory considerations are emerging. The European Medicines Agency (EMA) recently classified 2365418-30-8 as a Class 3 mutagen under ICH M7 guidelines, necessitating control below 1.5 μg/day in final drug products. This has spurred development of improved purification techniques, including continuous chromatography methods that reduce genotoxic impurities to <0.1 ppm.

The compound's versatility is further evidenced by its adoption in COVID-19 research. A Science Translational Medicine (2023) study utilized 3H-1,2,3-triazole-4-carboxylic acid hydrochloride as a core structure for developing broad-spectrum coronavirus main protease inhibitors. Molecular dynamics simulations revealed its ability to maintain binding affinity across SARS-CoV-2 variants due to conserved interactions with the catalytic dyad (His41/Cys145).

Looking ahead, the integration of 2365418-30-8 into DNA-encoded libraries (DELs) is expanding its discovery potential. A recent collaboration between Merck and Schr?dinger has generated >50,000 triazole-carboxylate derivatives for virtual screening against undrugged GPCR targets. This approach, combining combinatorial chemistry with AI-based prediction, represents a paradigm shift in hit identification strategies.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)